Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4329 (MIR4329) is a small, non-coding RNA molecule approximately 21–23 nucleotides in length, encoded by the MIR4329 gene on the human genome. Like other microRNAs, MIR4329 is believed to function in the regulation of gene expression by binding to complementary sequences in messenger RNA (mRNA) molecules, leading to translational repression or mRNA degradation. MicroRNAs play roles in a wide variety of cellular processes including development, differentiation, and disease pathogenesis, but the specific biological targets and functional relevance of MIR4329 remain uncharacterized in public scientific literature. More generally, microRNAs can serve as biomarkers and may become targets or tools in the field of RNA therapeutics[1][5].
Not applicable (no drugs directly targeting MIR4329 currently).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4329 (MIR4329).